Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

1.

Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.

Johnson TV, Ali S, Abbasi A, Kucuk O, Harris WB, Ogan K, Pattaras J, Nieh PT, Marshall FF, Osunkoya AO, Master VA.

J Urol. 2011 Oct;186(4):1213-7. doi: 10.1016/j.juro.2011.06.014. Epub 2011 Aug 17.

PMID:
21849188
[PubMed - indexed for MEDLINE]
2.

Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.

Johnson TV, Abbasi A, Owen-Smith A, Young A, Ogan K, Pattaras J, Nieh P, Marshall FF, Master VA.

J Urol. 2010 Feb;183(2):480-5. doi: 10.1016/j.juro.2009.10.014. Epub 2009 Dec 14.

PMID:
20006861
[PubMed - indexed for MEDLINE]
3.

Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.

Bui MH, Visapaa H, Seligson D, Kim H, Han KR, Huang Y, Horvath S, Stanbridge EJ, Palotie A, Figlin RA, Belldegrun AS.

J Urol. 2004 Jun;171(6 Pt 1):2461-6.

PMID:
15126876
[PubMed - indexed for MEDLINE]
4.

[Pathological prognostic indicators in renal cell carcinoma].

Rey Rey J, León Ramírez D, López García S, Fernández Vázquez P, Benavente Delgado J, Ojea Calvo A.

Actas Urol Esp. 2010 Jan;34(1):71-7. Spanish.

PMID:
20223135
[PubMed - indexed for MEDLINE]
5.

Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients.

Ali S, Yin-Goen Q, Johnson TV, Han W, Johnson NA, Harris WB, Marshall FF, Young AN, Master VA, Osunkoya AO.

Tumour Biol. 2011 Apr;32(2):375-80. doi: 10.1007/s13277-010-0130-9. Epub 2010 Nov 18.

PMID:
21086092
[PubMed - indexed for MEDLINE]
6.

Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.

Tatokoro M, Saito K, Iimura Y, Fujii Y, Kawakami S, Kihara K.

J Urol. 2008 Aug;180(2):515-9. doi: 10.1016/j.juro.2008.04.025. Epub 2008 Jun 11.

PMID:
18550105
[PubMed - indexed for MEDLINE]
7.

Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.

Komai Y, Saito K, Sakai K, Morimoto S.

BJU Int. 2007 Jan;99(1):77-80. Epub 2006 Sep 6.

PMID:
16956357
[PubMed - indexed for MEDLINE]
8.

The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.

Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.

J Urol. 2002 Jul;168(1):56-60.

PMID:
12050492
[PubMed - indexed for MEDLINE]
9.

Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.

Iimura Y, Saito K, Fujii Y, Kumagai J, Kawakami S, Komai Y, Yonese J, Fukui I, Kihara K.

J Urol. 2009 Mar;181(3):1004-12; discussion 1012. doi: 10.1016/j.juro.2008.10.156. Epub 2009 Jan 16.

PMID:
19150550
[PubMed - indexed for MEDLINE]
10.

Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.

Yoo C, Song C, Hong JH, Kim CS, Ahn H.

J Urol. 2008 Aug;180(2):486-91; discussion 491. doi: 10.1016/j.juro.2008.04.034. Epub 2008 Jun 11.

PMID:
18550101
[PubMed - indexed for MEDLINE]
11.

Prognostic significance of body mass index in Asian patients with localized renal cell carcinoma.

Komura K, Inamoto T, Black PC, Koyama K, Katsuoka Y, Watsuji T, Azuma H.

Nutr Cancer. 2011;63(6):908-15. doi: 10.1080/01635581.2011.594207. Epub 2011 Jul 29.

PMID:
21800976
[PubMed - indexed for MEDLINE]
12.

Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.

Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M.

J Urol. 2008 Oct;180(4):1284-9. doi: 10.1016/j.juro.2008.06.036. Epub 2008 Aug 15.

PMID:
18707725
[PubMed - indexed for MEDLINE]
13.

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A.

J Urol. 2000 Apr;163(4):1090-5; quiz 1295.

PMID:
10737472
[PubMed - indexed for MEDLINE]
14.

Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma.

Miyata Y, Koga S, Nishikido M, Noguchi M, Kanda S, Hayashi T, Saito Y, Kanetake H.

Urology. 2001 Aug;58(2):161-4.

PMID:
11489689
[PubMed - indexed for MEDLINE]
15.

Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma.

Michigan A, Johnson TV, Master VA.

Mol Diagn Ther. 2011 Aug 1;15(4):229-34. doi: 10.2165/11534900-000000000-00000.

PMID:
21756006
[PubMed - indexed for MEDLINE]
16.

Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.

Li G, Feng G, Gentil-Perret A, Genin C, Tostain J.

J Urol. 2008 Aug;180(2):510-3; discussion 513-4. doi: 10.1016/j.juro.2008.04.024. Epub 2008 Jun 11.

PMID:
18550116
[PubMed - indexed for MEDLINE]
17.

Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.

Isbarn H, Patard JJ, Lughezzani G, Rioux-Leclercq N, Crépel M, Cindolo L, de la Taille A, Zini L, Villers A, Shariat SF, Bertini R, Karakiewicz PI.

Urology. 2010 Jun;75(6):1378-84. doi: 10.1016/j.urology.2009.07.1221. Epub 2009 Sep 25.

PMID:
19781745
[PubMed - indexed for MEDLINE]
18.

Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.

Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM.

J Urol. 2001 Jul;166(1):68-72.

PMID:
11435825
[PubMed - indexed for MEDLINE]
19.

The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma.

Klatte T, Seligson DB, Leppert JT, Riggs SB, Yu H, Zomorodian N, Kabbinavar FF, Strieter RM, Belldegrun AS, Pantuck AJ.

J Urol. 2008 Jan;179(1):61-6. Epub 2007 Nov 13.

PMID:
17997430
[PubMed - indexed for MEDLINE]
20.

Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.

Serrano MF, Katz M, Yan Y, Kibel AS, Humphrey PA.

Cancer. 2008 Aug 1;113(3):477-83. doi: 10.1002/cncr.23574.

PMID:
18484589
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk